DK0593520T3 - Forbindelser med indhold af steroider og deres anvendelse til behandling af glaucom - Google Patents
Forbindelser med indhold af steroider og deres anvendelse til behandling af glaucomInfo
- Publication number
- DK0593520T3 DK0593520T3 DK92912769T DK92912769T DK0593520T3 DK 0593520 T3 DK0593520 T3 DK 0593520T3 DK 92912769 T DK92912769 T DK 92912769T DK 92912769 T DK92912769 T DK 92912769T DK 0593520 T3 DK0593520 T3 DK 0593520T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- glaucoma
- treatment
- content
- date
- Prior art date
Links
- 208000010412 Glaucoma Diseases 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 150000003431 steroids Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
- 230000003637 steroidlike Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9107412 | 1991-06-18 | ||
| FR9109017A FR2679139B1 (fr) | 1991-07-17 | 1991-07-17 | Nouvelles compositions pharmaceutiques destinees a l'application oculaire renfermant un derive androstenique et leur procede de preparation. |
| FR9109015A FR2679137B1 (fr) | 1991-07-17 | 1991-07-17 | Nouvelles compositions pharmaceutiques a base d'un derive pregnenique et leur procede de preparation. |
| FR9109016A FR2679138B1 (fr) | 1991-07-17 | 1991-07-17 | Compositions pharmaceutiques anti-glaucomateuses et leur procede d'obtention. |
| FR9110160A FR2680108B1 (fr) | 1991-08-09 | 1991-08-09 | Nouvelles compositions pharmaceutiques a base de sterouides 6-hydroxymethyles et leur procede d'obtention. |
| PCT/FR1992/000549 WO1992022300A1 (fr) | 1991-06-18 | 1992-06-18 | Compositions oculaires contenant des steroïdes et leur utilisation pour le traitement du glaucome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0593520T3 true DK0593520T3 (da) | 2000-04-03 |
Family
ID=27515565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92912769T DK0593520T3 (da) | 1991-06-18 | 1992-06-18 | Forbindelser med indhold af steroider og deres anvendelse til behandling af glaucom |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5506220A (da) |
| EP (1) | EP0593520B1 (da) |
| JP (1) | JP3328729B2 (da) |
| KR (1) | KR100249555B1 (da) |
| AT (1) | ATE185071T1 (da) |
| CA (1) | CA2111699A1 (da) |
| DE (1) | DE69230069T2 (da) |
| DK (1) | DK0593520T3 (da) |
| ES (1) | ES2139602T3 (da) |
| GR (1) | GR3031967T3 (da) |
| WO (1) | WO1992022300A1 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004091630A1 (ja) * | 2003-04-18 | 2004-10-28 | Advanced Medicine Research Institute | 眼に適用する疾患治療剤 |
| WO2004093882A1 (ja) * | 2003-04-18 | 2004-11-04 | Advanced Medicine Research Institute | 眼に適用する疾患治療剤 |
| JP5544458B2 (ja) * | 2005-07-12 | 2014-07-09 | アンピオ ファーマシューティカルズ,インコーポレイテッド | 疾病を治療するための医薬製品の製造においてトリロスタンiiiを使用する方法及びトリロスタンiiiを含む医薬製品 |
| EP2445350A4 (en) * | 2009-06-22 | 2012-12-26 | Dmi Acquisition Corp | METHOD AND PRODUCTS FOR THE TREATMENT OF DISEASES |
| NZ597030A (en) | 2009-06-22 | 2013-10-25 | Dmi Acquisition Corp | Method for treatment of diseases |
| CN102134265B (zh) * | 2009-12-29 | 2013-04-03 | 黄云生 | 一种合成6-甲基-17α-乙酰氧基-19-去甲孕甾-4,6-二烯-3,20-二酮的方法 |
| HRP20170502T1 (hr) * | 2011-05-20 | 2017-06-16 | Inserm - Institut National De La Santé Et De La Recherche Médicale | Antagonisti cb 1 receptora |
| CN105189529B (zh) | 2012-11-28 | 2017-09-05 | 国家医疗保健研究所 | 孕烯醇酮的3‑(4’‑取代的)‑苄基‑醚衍生物 |
| AU2013361338A1 (en) | 2012-12-19 | 2015-08-06 | Ampio Pharmaceuticals, Inc. | Method for treatment of diseases |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1515284A (en) * | 1974-05-21 | 1978-06-21 | Gastaud J | Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series |
| US4383992A (en) * | 1982-02-08 | 1983-05-17 | Lipari John M | Water-soluble steroid compounds |
| US4617299A (en) * | 1983-12-19 | 1986-10-14 | Knepper Paul A | Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension |
| US4863912A (en) * | 1986-05-19 | 1989-09-05 | New York Medical College | Use of tetrahydrocortisol in glaucoma therapy |
| WO1987007141A1 (en) * | 1986-05-23 | 1987-12-03 | New England Medical Center Hospitals, Inc. | Method for treating glaucoma |
| FR2622194B1 (fr) * | 1987-10-27 | 1990-03-23 | Theramex Laboratoire | Nouveaux derives de la 19-nor progesterone, leur procede d'obtention et les compositions pharmaceutiques en contenant |
| US4876250A (en) * | 1988-10-31 | 1989-10-24 | Alcon Laboratories, Inc. | Methods for controlling ocular hypertension with angiostatic steroids |
| FR2645864B1 (fr) | 1989-04-13 | 1991-07-12 | Theramex | Nouveaux derives alcoyles en 17/21 de la 19-nor progesterone, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant |
| FR2679236B1 (fr) | 1991-07-18 | 1997-01-24 | Theramex | Nouveaux sterouides substitues en position 6, leurs procedes d'obtention et des compositions pharmaceutiques en renfermant. |
-
1992
- 1992-06-18 DK DK92912769T patent/DK0593520T3/da active
- 1992-06-18 EP EP92912769A patent/EP0593520B1/fr not_active Expired - Lifetime
- 1992-06-18 WO PCT/FR1992/000549 patent/WO1992022300A1/fr not_active Ceased
- 1992-06-18 DE DE69230069T patent/DE69230069T2/de not_active Expired - Fee Related
- 1992-06-18 US US08/170,179 patent/US5506220A/en not_active Expired - Fee Related
- 1992-06-18 AT AT92912769T patent/ATE185071T1/de not_active IP Right Cessation
- 1992-06-18 ES ES92912769T patent/ES2139602T3/es not_active Expired - Lifetime
- 1992-06-18 KR KR1019930703965A patent/KR100249555B1/ko not_active Expired - Fee Related
- 1992-06-18 CA CA002111699A patent/CA2111699A1/fr not_active Abandoned
- 1992-06-18 JP JP50077393A patent/JP3328729B2/ja not_active Expired - Fee Related
-
1999
- 1999-11-26 GR GR990403060T patent/GR3031967T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5506220A (en) | 1996-04-09 |
| JPH06508362A (ja) | 1994-09-22 |
| DE69230069D1 (de) | 1999-11-04 |
| EP0593520B1 (fr) | 1999-09-29 |
| CA2111699A1 (fr) | 1992-12-23 |
| KR940701260A (ko) | 1994-05-28 |
| GR3031967T3 (en) | 2000-03-31 |
| WO1992022300A1 (fr) | 1992-12-23 |
| EP0593520A1 (fr) | 1994-04-27 |
| DE69230069T2 (de) | 2000-05-25 |
| ATE185071T1 (de) | 1999-10-15 |
| JP3328729B2 (ja) | 2002-09-30 |
| ES2139602T3 (es) | 2000-02-16 |
| KR100249555B1 (ko) | 2000-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2162260A1 (en) | Methods and formulations for use in treating oophorectomized women | |
| DK0538443T3 (da) | Fremgangsmåde og formuleringer til kontraception og til behandling af godartede gynækologiske forstyrrelser | |
| HK1056181A1 (zh) | 作為抗炎劑的17β-硫代羧酸酯17α-芳基羰氧基氧雄甾烷衍生物 | |
| DK0581959T3 (da) | Anvendelse af makrolidforbindelser til øjensygdomme | |
| BE2015C026I2 (en) | 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens | |
| ATE184598T1 (de) | Enniatine und enniatinderivate zur bekämpfung von endoparasiten | |
| IL97025A0 (en) | 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives,their preparation and pharmaceutical compositions containing them | |
| UA39158C2 (uk) | Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі | |
| IL108520A0 (en) | Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them | |
| DK0682664T3 (da) | Forbindelser med både potent calciumantagonist og antioxiderende aktivitet og anvendelse deraf som cytobeskyttende midler | |
| DE69432752D1 (de) | Zusammensetzung zur substitutionstherapie, die mindestens ein progestogen und mindestens ein oestrogen enthält | |
| AU2291097A (en) | Novel phenanthridines substituted in the 6 position | |
| DE60040753D1 (de) | Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden | |
| DK1056454T3 (da) | Anvendelse af makrolidforbindelser til behandling af glaukom | |
| ATE180781T1 (de) | Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung | |
| DK0593520T3 (da) | Forbindelser med indhold af steroider og deres anvendelse til behandling af glaucom | |
| KR970061246A (ko) | 테스토스테론을 증가시키기 위한 약학 조성물 | |
| TR200000153T2 (tr) | İl-5 inhibite eden 6-azaurasil türevleri. | |
| BR1100143A (pt) | Composto, e, composição farmacêutica. | |
| DK0613687T3 (da) | Anvendelse af pregnanderivat til behandling af tumorer | |
| KR930012036A (ko) | 골 흡수 억제용 약제학적 조성물 | |
| IL109866A0 (en) | Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (+) l-hydrogentartrate, its preparation and pharmaceutical compositions containing it | |
| HUP0300887A2 (hu) | Szteroid szerkezeteket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| GR3034142T3 (en) | Composition for the treatment or prevention of herpes | |
| IL83088A (en) | Substituted 3-isoquinolinols,their preparation and pharmaceutical compositions containing them |